| Q44213246 | A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus |
| Q50888231 | Antral endocrine cells in nonobese diabetic mice. |
| Q33787539 | Cellular pathogenesis of diabetic gastroenteropathy. |
| Q53083035 | Diabetes and the Stomach. |
| Q37554194 | Diabetes mellitus and gastric emptying: questions and issues in clinical practice |
| Q39427195 | Diabetes-induced mechanophysiological changes in the small intestine and colon |
| Q38587718 | Diabetes-related dysfunction of the small intestine and the colon: focus on motility |
| Q33782095 | Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes |
| Q37507919 | Diabetic gastroparesis: diagnosis and management |
| Q35068007 | Diabetic gastropathy and prokinetics |
| Q43967110 | Domperidone is more effective than cisapride in children with diabetic gastroparesis. |
| Q77428141 | Domperidone. A review of its use in diabetic gastropathy |
| Q41213460 | Dyspeptic symptoms in patients with type 1 diabetes: endoscopic findings, Helicobacter pylori infection, and associations with metabolic control, mood disorders and nutritional factors |
| Q44833656 | Effect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations |
| Q48271978 | Effects of hyperglycemia on cortical response to esophageal distension in normal subjects |
| Q44325721 | Gastric emptying in animal models of human diabetes: correlation to blood glucose level and gut neuroendocrine peptide content |
| Q34579697 | Gastric emptying in diabetes: clinical significance and treatment. |
| Q33596334 | Gastrointestinal signs and symptoms among persons with diabetes mellitus |
| Q44325724 | Gastrointestinal transit in an animal model of human diabetes type 2: relationship to gut neuroendocrine peptide contents |
| Q43740714 | Gastrointestinal transit in nonobese diabetic mouse: an animal model of human diabetes type 1. |
| Q36947379 | Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment. |
| Q38966374 | Gastroparesis post-laparoscopic cholecystectomy in diabetic patients |
| Q43980742 | Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus |
| Q73792745 | Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus |
| Q51576547 | Hyperglycemia affects gastric electrical rhythm and nausea during intraduodenal triglyceride infusion. |
| Q31987954 | Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life |
| Q43521785 | Impairment of the proximal to distal tonic gradient in the human diabetic stomach |
| Q55091605 | Lower gastrointestinal symptoms are associated with worse glycemic control and quality of life in type 1 diabetes mellitus. |
| Q39041935 | Management of chronic constipation in patients with diabetes mellitus |
| Q37870314 | Mycophenolic acid in kidney transplant patients with diabetes mellitus: does the formulation matter? |
| Q80138062 | Oesophageal motility disorders in type 1 diabetes mellitus and their relation to cardiovascular autonomic neuropathy |
| Q31795272 | Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. |
| Q36903737 | Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists. |
| Q28217275 | Peptide YY in gastrointestinal disorders |
| Q51067220 | Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. |
| Q39264015 | Role of wireless motility capsule in the assessment and management of gastrointestinal dysmotility in patients with diabetes mellitus |
| Q26740345 | Screening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversy |
| Q44318833 | Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults |
| Q64091567 | Targeted genotyping for the prediction of celiac disease autoimmunity development in patients with type 1 diabetes and their family members |
| Q58805218 | The association between diabetes mellitus and Helicobacter pylori infection |
| Q37445279 | The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus |
| Q84766390 | The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis |
| Q33703912 | The role of peptide YY in gastrointestinal diseases and disorders (review). |
| Q33867705 | Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus |
| Q47906168 | Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis |